Prostate Cancer Foundation Statement on U.S. Preventive Services Task Force Updated Prostate Screening Guidelines
Yesterday, the USPSTF updated its 2012 position on prostate cancer screening recommending that clinicians should selectively offer or provide periodic prostate-specific antigen (PSA)–based screening for prostate cancer for men between...Read More
Clinical trial finds strong promise for new treatment that targets radiation directly to prostate cancer
May 8, 2018 A study published today in Lancet Oncology reported highly promising results from a phase 2 clinical trial testing a new treatment, 177Lu-PSMA-617, which targets radiation directly to prostate...Read More
PCF-funded investigators report progress on a promising new treatment for a highly lethal form of prostate cancer
Prostate cancer cells depend on androgens to grow and thrive. Because of this dependency, hormone therapy – the blockade of androgens and the androgen receptor (AR) – has been the...Read More
2018 AACR-Prostate Cancer Foundation Scholar-in-Training Award Recipients
Mark P. Labrecque, PhD University of Washington, Seattle, WA Abstract # 1092 Defining the molecular phenotypes of metastatic castration-resistant prostate cancer sensitive to FGF pathway inhibition M. P. Labrecque1, L....Read More
Actor and Comedian Chris Tucker Partners With The Prostate Cancer Foundation During National Minority Health Month to Create Awareness About the Increased Risks for African-American Men and Challenges Them to “Know the Numbers”
SANTA MONICA, Calif., April 3, 2018 -- The Prostate Cancer Foundation (PCF) announced today that actor, comedian and humanitarian Chris Tucker (Rush Hour) will join its National Minority Health Month initiative as a spokesperson...Read More
Scientists uncover “long tail” of nearly 100 genes mutated in prostate cancer
APRIL 2, 2018 -- Issued by Dana-Farber Cancer Institute. By sequencing DNA in more than 1,000 patient samples, researchers have identified a total of 97 genes significantly mutated in prostate...Read More
New Study indicates 18 months of androgen deprivation therapy may be optimal for locally advanced prostate cancer
Results from the RADAR clinical trial presented at the 2018 ASCO Genitourinary Cancer Symposium indicate that 18 months of ADT could very likely become the new standard of care. The...Read More
Kristen Bell Chooses Winners of The Prostate Cancer Foundation’s 1st Annual TRUE Love Campaign Honoring Caregivers of Prostate Cancer Patients
SANTA MONICA, Calif., March 13, 2018 – The winners of the 1st Annual TRUE Love Campaign honoring caregivers of prostate cancer patients were announced today by the Prostate Cancer Foundation...Read More
New NCCN Guidelines Incorporate PCF-Funded Research on Cancer Risk Genes
Thanks in large part to the kinds of genetic and precision medicine that the Prostate Cancer Foundation has been funding, the National Comprehensive Cancer Network (NCCN) has issued updated prostate...Read More
Prostate Cancer Loves Couch Potatoes
Hey, guys: If you think exercise is just about pumping iron and getting big traps, six-pack abs and “gun show” biceps, your prostate would like to disagree. To your prostate,...Read More